Industries > Pharmaceutical/Biotech | SupplyChainBrain
Webinars
Podcasts
Videos
Events
Subscribe
Sign In
Logistics
Air Cargo
All Logistics
Facility Location Planning
Freight Forwarding/Customs Brokerage
Global Gateways
Global Logistics
Last Mile Delivery
Logistics Outsourcing
LTL/Truckload Services
Ocean Transportation
Parcel & Express
Rail & Intermodal
Reverse Logistics
Service Parts Management
Transportation & Distribution
Technology
All Technology
Artificial Intelligence
Cloud & On-Demand Systems
Data Management (Big Data/IoT/Blockchain)
ERP & Enterprise Systems
Forecasting & Demand Planning
Global Trade Management
Inventory Planning/Optimization
Product Lifecycle Management
Robotics
Sales & Operations Planning
SC Finance & Revenue Management
SC Planning & Optimization
Supply Chain Visibility
Transportation Management
General SCM
Business Strategy Alignment
Customer Relationship Management
Education & Professional Development
Global Supply Chain Management
Global Trade & Economics
Green Energy
HR & Labor Management
Quality & Metrics
Regulation & Compliance
Sourcing/Procurement/SRM
SC Security & Risk Mgmt
Supply Chains in Crisis
Sustainability & Corporate Social Responsibility
Warehousing
All Warehouse Services
Conveyors & Sortation
Lift Trucks & AGVs
Order Management & Fulfillment
Packaging
RFID, Barcode, Mobility & Voice
Warehouse Automation
Warehouse Management Systems
Industries
Aerospace & Defense
Apparel
Automotive
Chemicals & Energy
Consumer Packaged Goods
E-Commerce/Omni-Channel
Food & Beverage
Healthcare
High-Tech/Electronics
Industrial Manufacturing
Pharmaceutical/Biotech
Retail
Think Tank
Pharmaceutical/Biotech: Page 43
The LogiMed Virtual Event: Improving Your End-To-End Supply Chain During Turbulent Times
The LogiMed Virtual Event will provide you with insights and resources from your peers who are also working through unprecedented challenges at their organizations.
Europe Finds It’s Hard to Say Goodbye to Low-Cost China
Already buffeted by U.S.-China trade tensions, the European Union has stepped efforts to produce closer to home in the wake of the global pandemic.
Podcast | How to Break America’s Reliance on Manufacturing in China
The coronavirus pandemic has revealed the need for breaking the United States’ dependence on manufacturing in China and other countries.
Watch: Keeping Up With the FDA During the Pandemic
Claudia Lewis, partner with Venable LLP, describes how the U.S. Food and Drug Administration is revising its policies, practices and regulations in response to the coronavirus pandemic.
Here’s How a No-Deal Brexit Would Shock Virus-Hit U.K. Companies
Trade talks between the EU and U.K. have struggled in recent weeks, increasing the prospect that Britain departs the bloc without a deal and that businesses face an extreme shock when the divorce takes effect.
Can the U.S. End China’s Control of the Global Supply Chain?
The trade war amplified calls in the U.S. and elsewhere for reducing dependence on China for strategic goods. Now, the pandemic has politicians vowing to take action.
Watch: Curing the Healthcare Supply Chain
Christopher Tang, professor at UCLA's Anderson School of Management, describes what it will take for hospital and healthcare supply chains to recover from the COVID-19 pandemic.
COVID-19 Has Revealed Fatal Flaws in the U.S. Drug Supply Chain
The U.S. is seeing dangerous effects from an over-reliance on offshore manufacturers.
FDA Misled Senators on China’s Role as Vital U.S. Drug Supplier
The Food and Drug Administration had to walk back testimony by an official at a Senate hearing last week after he downplayed the scale of China’s dominance of the drug supply chain in the U.S.
200,000 Ship Crew Stuck at Sea Facing ‘Humanitarian Crisis’
Even as countries try returning to some semblance of pre-pandemic life, ongoing restrictions are wearing thin a crucial human link in the global supply chain.
Another Challenge for Vaccine Makers: Keeping It at Minus-112 Degrees
A little-known biotech is working to surmount a hurdle that may hinder global access to a coronavirus vaccine.
Trump Is Investing Millions to Bring Drugmaking Back to the U.S.
The Trump administration plans to pump millions of dollars into producing more medications in the U.S. as the coronavirus pandemic heightens longstanding concerns about the fragility of the global drug supply chain.
Previous Page
Page 43 of 336
Next Page
Sign me up!
Receive the latest supply chain trends, news and analysis from SupplyChainBrain.
Email Address
*
Sign Up
Featured Product
Case Studies
Case Studies
How a Leading U.S. Floral Distribution Company Reduced Warehouse Labor Costs by 45% with RFID
Case Studies
Recycled Tagging Fasteners: Small Changes Make a Big Impact
Case Studies
Enhancing High-Value Electronics Shipment Security with Tive's Real-Time Tracking
Case Studies
Moving Robots Site-to-Site